Improvement rate of patients with highest temperature during hospitalisation < 39.50C is significantly higher than other ones Conclusion: Children with stage IIB of HFMD treated by gammaglobulin have a high improvement rate (93.6%), lower mortality, (0.9%) and side effects are not significant.